Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.40.7379
Full Text
Open PDFAbstract
Available in full text
Date
September 20, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)